Literature DB >> 26756425

Different Advanced Therapeutic Approaches to Treat Vitiligo.

Chandra Kant Sharma1, Monika Sharma1, Bhawna Aggarwal1, Vinay Sharma1.   

Abstract

Vitiligo is a hypopigmentation disorder that is caused by the loss of melanocyte activity for melanin pigment generation. Vitiligo is distinguished by the existence of white macules. Vitiligo affects 0.1%-2% of individuals of different populations, irrespective of skin color, ethnic origin, race, or age. Although the actual mechanism behind this disease is not yet known, it is thought to be caused by a cumulative effect of various mechanisms (e.g., neurohormonal, genetic, cytotoxic, oxidative stress, autoimmune, and biochemical). This article reviews the published literature on various treatment modalities that might be effective in successfully treating patients with vitiligo, including phototherapies or some photochemotherapies, vitamin D analogs, topical and systemic corticosteroids, zinc treatment, anti-tumor necrosis factor agents, calcineurin inhibitors (tacrolimus, pimecrolimus), and surgical methods. This critical review also discusses a few herbal medications that may be worthy of future investigation because they have no significant side effects.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26756425     DOI: 10.1615/jenvironpatholtoxicoloncol.2015014168

Source DB:  PubMed          Journal:  J Environ Pathol Toxicol Oncol        ISSN: 0731-8898            Impact factor:   3.567


  1 in total

1.  Repigmentation of Tenacious Vitiligo on Apremilast.

Authors:  Sara B Huff; Lorie D Gottwald
Journal:  Case Rep Dermatol Med       Date:  2017-11-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.